Follicular large cell lymphoma: analysis and prognostic factors in 62 patients - PubMed (original) (raw)
Follicular large cell lymphoma: analysis and prognostic factors in 62 patients
H M Kantarjian et al. J Clin Oncol. 1984 Jul.
Abstract
Sixty-two patients with follicular large cell lymphoma were treated between 1973 and 1981. The overall median survival was 78 months with a five-year survival of 62%. The complete remission rate was 76%, with a median relapse-free interval of 72 months for responders. Complete remission produced a significantly longer survival than partial response and failure. Patients who tolerated therapy with an intensive doxorubicin-containing regimen had a significantly longer relapse-free interval and survival. Patients with stage I-II disease treated with radiation therapy alone had a higher relapse rate than those treated with radiation and combination chemotherapy. The addition of radiation therapy to combination chemotherapy in stage III-IV disease decreased the incidence of relapse at irradiated sites, but did not translate into improved survival. Pretreatment prognostic factors associated with poor response were thrombocytosis and stage III-IV disease; those associated with shortened survival were thrombocytosis, elevated lactic dehydrogenase level, stage III-IV disease, and bulky abdominal disease. Follicular large cell lymphoma is an aggressive lymphoma. Treatment should be curative in intent, and should include intensive combination chemotherapy even in stage I-II disease. Knowledge of important prognostic factors can be useful for analysis of future trials and planning therapeutic strategies.
Similar articles
- Follicular lymphoma: prognostic factors for response and survival.
Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS, Malpas JS, Lister TA. Gallagher CJ, et al. J Clin Oncol. 1986 Oct;4(10):1470-80. doi: 10.1200/JCO.1986.4.10.1470. J Clin Oncol. 1986. PMID: 3531422 - Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P. Seymour JF, et al. J Clin Oncol. 2003 Jun 1;21(11):2115-22. doi: 10.1200/JCO.2003.07.111. J Clin Oncol. 2003. PMID: 12775737 Review. - Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
Ott OJ, Rödel C, Gramatzki M, Niedobitek G, Sauer R, Grabenbauer GG. Ott OJ, et al. Strahlenther Onkol. 2003 Oct;179(10):694-701. doi: 10.1007/s00066-003-1062-8. Strahlenther Onkol. 2003. PMID: 14566478 - Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB. Hagemeister FB. Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review. - Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F, López-Guillermo A, Arenillas L, Montoto S, Giné E, Muntañola A, Ferrer A, Villamor N, Bosch F, Colomo L, Balaguer O, Campo E, Montserrat E. Plancarte F, et al. Eur J Haematol. 2006 Jan;76(1):58-63. doi: 10.1111/j.1600-0609.2005.00564.x. Eur J Haematol. 2006. PMID: 16343272
Cited by
- A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.
Rohatiner A, Radford J, Deakin D, Earl H, Love SB, Price O, Wilson A, Lister TA. Rohatiner A, et al. Br J Cancer. 2001 Jul 6;85(1):29-35. doi: 10.1054/bjoc.2001.1822. Br J Cancer. 2001. PMID: 11437398 Free PMC article. Clinical Trial. - Current approaches to the treatment of advanced-stage non-Hodgkin's lymphoma.
Rusthoven JJ. Rusthoven JJ. CMAJ. 1987 Jan 1;136(1):29-36. CMAJ. 1987. PMID: 3539298 Free PMC article. Review. - Clinical aspects of early stage non-Hodgkin's lymphoma.
Mead GM. Mead GM. Br J Cancer. 1990 Jan;61(1):7-8. doi: 10.1038/bjc.1990.3. Br J Cancer. 1990. PMID: 2404510 Free PMC article. Review. No abstract available. - Involved field radiotherapy or chemotherapy in the management of stage I nodal intermediate grade non-Hodgkin's lymphoma.
Jeffery GM, Mead GM, Whitehouse JM, Ryall RD. Jeffery GM, et al. Br J Cancer. 1991 Nov;64(5):933-7. doi: 10.1038/bjc.1991.429. Br J Cancer. 1991. PMID: 1931619 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources